SEC 01design + devREV 2025

Avenzoar Pharmaceuticals

SEC 02

Overview

Pre-clinical pharma company developing AI-enabled precision oncology therapeutics. Built in collaboration with design partner Matthew Fram.

SEC 03

The Work

Designed and developed the full site with Matthew Fram handling visual design. AI/technology platform pages, team profiles, pipeline information, and regulatory-ready content. Clean, scientific, and credible.

[ Design by Matthew Fram ]

SEC 04

Engagement

The site launched in 2025. DXD continues to maintain it, including content and team updates.

SEC 06

Tech

[ Webflow ][ Custom Design ][ Pharma/Biotech ][ Animation ]
SEC 07

Related work